A.H.M. Froon - Concepedia

Author

A.H.M. Froon

Also Known As

A FROON, A H Froon, A H M FROON, A H M Froon, A. Froon, A. H. M. Froon, A.H. Froon, A.H.M. Froon, ALBERT H. M. FROON, ALBERT H. M. FROON

Publications

677

Citations

H-Index

Concepts

All Affiliations

Maastricht University Medical Centre Maastricht University

About

A.H.M. Froon is an author at Maastricht University Medical Centre specializing in inflammation, medicine, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	257
2	Immunology	3	3	257
3	Emergency Medicine	2	2	129
4	Health Sciences	1	1	31
5	Microbiology	1	1	128

A.H.M. Froon

Publications

657

Citations

H-Index

Page 1

	Year	Citations
Lipopolysaccharide Toxicity-Regulating Proteins in Bacteremia A.H.M. Froon, Mieke A. Dentener, Júlia María D’Andréa Greve, The Journal of Infectious Diseases InflammationLipopolysaccharide Toxicity-regulating ProteinsMedical MicrobiologyAntimicrobial SusceptibilityLbp Plasma Levels	1995	128
<scp>d</scp>-lactate as an early marker of intestinal ischaemia after ruptured abdominal aortic aneurysm repair Martijn Poeze, A.H.M. Froon, Jan Greve, British journal of surgery	1998	107
The Systemic Inflammatory Response in the Development of Ventilator-Associated Pneumonia Marc J. M. Bonten, A.H.M. Froon, J.W.M. Greve, American Journal of Respiratory and Critical Care Medicine Acute Lung InjuryInflammationInflammatory Lung DiseaseLung InflammationRespiratory Diseases	1997	98
Increased plasma concentrations of soluble tumor necrosis factor receptors in sepsis syndrome A.H.M. Froon, Marc H.A. Bemelmans, JAN WILLEM GREVE, Critical Care Medicine	1994	82
Prediction of Clinical Severity and Outcome of Ventilator-associated Pneumonia A.H.M. Froon, Marc J. M. Bonten, J.W.M. Greve, American Journal of Respiratory and Critical Care Medicine	1998	59
DECREASED ORGAN FAILURE IN PATIENTS WITH SEVERE SIRS AND SEPTIC SHOCK TREATED WITH THE PLATELET-ACTIVATING FACTOR ANTAGONIST TCV-309: A PROSPECTIVE, MULTICENTER, DOUBLE-BLIND, RANDOMIZED PHASE II TRIAL Martijn Poeze, A.H.M. Froon, Graham Ramsay, Shock	2000	58
Increased concentrations of cytokines and adhesion molecules in patients after repair of abdominal aortic aneurysm. A.H.M. Froon, J.W.M. Greve, Josje van der Linden, PubMed	1996	55
Presence Of Bactericidal/Permeability-Increasing Protein In Disease: Detection By Elisa Mieke A. Dentener, Gaby J.M. Francot, F. T. Smit, The Journal of Infectious Diseases	1995	39
TREATMENT WITH THE PLATELET-ACTIVATING FACTOR ANTAGONIST TCV-309 IN PATIENTS WITH SEVERE SYSTEMIC INFLAMMATORY RESPONSE SYNDROME: A PROSPECTIVE, MULTI-CENTER, DOUBLEBLIND, RANDOMIZED PHASE II TRIAL; A.H.M. Froon, Jan Greve, Wim A. Buurman, Shock ImmunologyPharmacotherapyImmunotherapyInflammationThrombosis	1996	31

Page 1